14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
RVT vs HQL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Royce Small-Cap Trust, Inc. (RVT) is the stronger overall head-to-head candidate over abrdn Life Sciences Investors (HQL) in the Tradestie Institutional Equity Comparison Engine, winning 4–0 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). RVT carries a Unified Composite Score of 47.7/100 (HOLD) at $16.66 (N/M Forward P/E, N/A operating margin), whereas HQL carries 46.0/100 (HOLD) at $17.81 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: RVT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8); meanwhile HQL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RVT vs HQL. Trailing 12-month operating profitability (RVT N/A vs HQL N/A) and valuation multiples (RVT N/M vs HQL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $455.0M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ RVT vs HQL Key Questions & Quantitative Answers
As of Nov 16, 2026, Royce Small-Cap Trust, Inc. (RVT) is the stronger overall head-to-head candidate over abrdn Life Sciences Investors (HQL) in the Tradestie Institutional Equity Comparison Engine, winning 4–0 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). RVT carries a Unified Composite Score of 47.7/100 (HOLD) at $16.66 (N/M Forward P/E, N/A operating margin), whereas HQL carries 46.0/100 (HOLD) at $17.81 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: RVT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8); meanwhile HQL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
RVT leads the Growth & Scale pillar: RVT posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HQL at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, RVT generates N/A in USD-normalized revenue versus N/A for HQL. In operating R&D and SG&A reinvestment, RVT deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HQL.
RVT and HQL trade at balanced relative valuation multiples. RVT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HQL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RVT (N/A ROE) versus HQL (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, RVT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 26% Vol realized risk). By comparison, HQL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.91β · 39% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.